The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 160.00
Ask: 170.00
Change: -3.50 (-2.08%)
Spread: 10.00 (6.25%)
Open: 168.50
High: 168.50
Low: 162.00
Prev. Close: 168.50
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Syndicate Mid Point Forecasts

4 Apr 2023 07:00

RNS Number : 2139V
Helios Underwriting Plc
04 April 2023
 

4th April 2023

 

Helios Underwriting plc

('Helios' or 'the Company')

 

Quarterly Syndicate Mid Point Forecasts

 

Helios, the unique investment vehicle which acquires and consolidates private underwriting capacity at Lloyd's, announces the current mid-point forecasts in respect of its portfolio of syndicate capacity for the 2020 and 2021 years of account based on 4th quarter 2022 estimates.

 

Martin Reith, Chief Executive, commented:

 

"Helios' unique proposition, as the only listed consolidator of private capital at Lloyd's, is well positioned to benefit from the Lloyd's market's recently announced mid point forecasts. Helios has built and curated an outstanding portfolio of the better performing syndicates and, as a consequence of underwriting discipline and judicious capital deployment, we are delighted to see improved underwriting profitability in the Lloyd's market. We expect Helios' portfolio to continue to outperform the market as we have since 2013 for closed years of accounts.

 

Recognising stronger market conditions, we increased our retained capacity to £238m for the 2023 year of account, an increase of 34%. We remain confident that we shall deliver improved results and superior return on equity underpinned by our favourable Economic Capital Assessment (ECA), and look forward to creating further shareholder value as the benefits of the larger retained capacity flows to the income statement."

 

Year of Account

 

 

2020

2021

2022

2023

 

 

£m

£m

£m

£m

 

Capacity - Position as at 30th September 2022

 

Retained

66.5

93.5

171.9

 

Reinsured

49.1

51.5

60.8

 

115.6

145.0

232.7

 

Capacity Acquired since 30th September 2022

 

 

Retained

5.6

5.8

5.7

 

Reinsured

0.0

0.0

0.0

 

5.6

5.8

5.7

 

Total capacity as at 31st March 2023

 

Retained

72.0

99.3

177.6

238.4

 

Reinsured

49.1

51.5

60.8

58.3

 

121.2

150.8

238.4

296.7

 

Mid-point forecast at 30th September 2022

1.94%

2.29%

 

Final result / Current mid-point forecast

3.11%

2.37%

 

Lloyd's Market Average

0.91%

4.20%

 

Helios out performance

2.20%

(1.83)%

 

 

Commentary

 

The 2020 result showed an improvement over the midpoint forecasts as at 30th September 2022. The overall result was impacted by the negative investment returns recognised during the year and the impact from the COVID-19 pandemic.

 

The development of the mid point estimate for 2021 has been held back by losses from Ukraine that were recognised in 2022. The improved returns from the investment portfolio should benefit this year before it closes at the end of this year.

 

The 2022 underwriting year has been impacted by the loss from Hurricane Ian that will create a drag on the earnings recognised in 2022.

 

The outperformance of 2.2% of the portfolio against the average for the Lloyd's market for 2020 continues the trend of closed year of account outperformance achieved since 2013.

 

Notes

1) The table above shows the capacity as at 31st March 2023, splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers. 

2) The mid-point forecasts for 2020 and 2021 years of account as of 4th quarter 2022 have been aggregated at syndicate level from estimates supplied by Managing Agents.

3) The impact on Helios will be as follows:

a. The change in the mid point estimates on the retained capacity over the year will be recognised in the Helios income statement in the year to 31st December 2022.

b. The overall change in the result will be recognised by Helios in cash at the close of the year of account.

 

For further information, please contact:

Helios Underwriting plc

 

Helios Underwriting plc

Martin Reith - Chief Executive +44(0)7720 292 505

Nigel Hanbury - Executive Deputy Chairman +44(0)7787 530 404

Arthur Manners - Chief Financial Officer +44(0)7754 965 917

 

Shore Capital

Robert Finlay +44(0)20 77408 4080

David Coaten

Henry Willcocks

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £297m of capacity for the 2023 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUGACUPWGAW
Date   Source Headline
30th Jun 20157:00 amRNSIssue of Equity
25th Jun 20154:11 pmRNSResult of AGM
19th Jun 201511:47 amRNSDirector/PDMR Shareholding
12th Jun 20155:25 pmRNSCompletion of Acquisition
12th Jun 20157:00 amRNSScript Dividend Reference Price
5th Jun 20157:00 amRNSSyndicate Forecasts
2nd Jun 20159:42 amRNSPosting of Annual Report & Notice of AGM
26th May 20158:06 amRNSFinal Results
31st Mar 201512:04 pmRNSTotal Voting Rights
17th Mar 20157:00 amRNSSyndicate Forecasts
13th Mar 20154:02 pmRNSAcquisition
11th Mar 201511:35 amRNSDirector/PDMR Shareholding
20th Feb 20154:12 pmRNSCompletion of Acquisition
18th Feb 20153:45 pmRNSDirector/PDMR Shareholding
18th Feb 20157:00 amRNSDirector/PDMR Shareholding
17th Feb 20157:00 amRNSAcquisition
16th Feb 20157:00 amRNSAcquisition
13th Feb 20154:08 pmRNSHolding(s) in Company
12th Feb 20157:00 amRNSAcquisition
9th Jan 20157:00 amRNSAcquisition
19th Dec 20143:55 pmRNSChange of Registered Office
19th Dec 20143:38 pmRNSAcquisition
26th Nov 20147:00 amRNSSyndicate Forecasts
29th Sep 20147:00 amRNSHalf Yearly Report
17th Sep 201411:52 amRNSCompletion of Acquisition
27th Aug 20147:00 amRNSSyndicate Forecasts
23rd Jul 20143:51 pmRNSSyndicate Forecasts
23rd Jul 20141:44 pmRNSHolding(s) in Company
23rd Jul 20147:00 amRNSHolding(s) in Company
14th Jul 20143:32 pmRNSHolding(s) in Company
14th Jul 20147:00 amRNSHUW Secures Stop Loss Cover
9th Jul 20147:00 amRNSAcquisition
8th Jul 20143:40 pmRNSHolding(s) in Company
1st Jul 201412:21 pmRNSHolding(s) in Company
30th Jun 20145:45 pmRNSHolding(s) in Company
30th Jun 20147:00 amRNSReinsurance Agreements
27th Jun 201410:03 amRNSResult of AGM
4th Jun 20147:00 amRNSPosting of Annual Report & Notice of AGM
23rd May 20147:00 amRNSFinal Results
8th May 20149:04 amRNSCompletion of Acquisition
2nd May 20141:17 pmRNSAcquisition of Lloyd's Member
28th Mar 20147:00 amRNSAcquisition of Corporate Member
27th Mar 20147:00 amRNSSyndicate Forecasts
12th Mar 20147:00 amRNSChange of Adviser
5th Mar 201411:30 amRNSMembers' Agent's Agreements
20th Feb 20143:57 pmRNSHolding(s) in Company
30th Jan 20142:17 pmRNSDirector/PDMR Shareholding
27th Jan 20147:00 amRNSChange of Name
17th Jan 20143:13 pmRNSCompletion of Acquisitiion
13th Jan 20141:34 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.